Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm

Infection Control and Hospital Epidemiology

Volumn 26, Issue 6, 2005, Pages 515-519

  Percival, Steven L ^a,b   Kite, Peter ^a   Eastwood, Kerrie ^a   Murga, Ricardo ^b   Carr, Janice ^b   Arduino, Matthew J ^b   Donlan, Rodney M ^b  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDETATE SODIUM;

ARTICLE; BACTERIUM CULTURE; BIOFILM; CANDIDA ALBICANS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COLONY FORMING UNIT; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFECTIVE AGENTS; BIOFILMS; CANDIDA ALBICANS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CELL COUNT; CHELATING AGENTS; CROSS INFECTION; DRUG EVALUATION, PRECLINICAL; EDETIC ACID; EQUIPMENT CONTAMINATION; ESCHERICHIA COLI; HUMANS; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; PSEUDOMONAS AERUGINOSA; SEPSIS; SONICATION; SPECIMEN HANDLING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS;

EID: 21244503949     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502577     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;10:1-28.
2. Anaissie EG, Samonis G, Kontoyiannis D, et al. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 1995;14:135-137.
3. Dasgupta MK. Biofilms and infection in dialysis patients. Semin Dial 2002;15:338-346.
4. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In: Bisno AL, Waldvogel FP, eds. Infections Associated With Indwelling Medical Devices, ed. 2. Washington, DC: American Society for Microbiology Press; 1994:155-212.
5. Raad I, Costerton W, Sabharwal U, Sacilowski M, Annaissie W, Brodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400-407.
6. Donlan RM, Murga R, Bell M, et al. Protocol for detection of biofilms on needleless connectors attached to central venous catheters. J Clin Microbiol 2001;39:750-753.
7. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973;79:867-887.
8. Raad I. Intravascular-catheter-related infections. Lancet 1998;351:893-898.
9. Carratala J. The antibiotic-lock technique for therapy of "highly needed" infected catheters. Clin Microbiol Infect 2000;8:282-289.
10. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic vents in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomised, multicenter, double blind trial. J Clin Oncol 2000;18:1269-1278.
11. Berrington A, Gould FK. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 2001;48:597-603.
12. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
13. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999;43:2200-2204.
14. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunnelled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990;8:1591-1597.
15. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995;127:147-151.
16. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-1272.
17. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987;316: 927-931.
18. Kaplan AH, Gilligan PH, Facklam RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988;26:1216-1218.
19. Sieradzki K, Leski T, Dick J, Borio L, Tomasz A. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy. J Clin Microbiol 2003;41:1687-1693.
20. Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002;46:1674-1679.
21. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP. Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 1988;32:1627-1631.
22. Raad I, Buzaid A, Rhyne J, et al. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997;25:149-151.
23. Kite P, Eastwood K, Sugden S, Percival SL. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 2004;42:3073-3076.
24. Russell AD. Ethylenediaminetetra-acetic acid. In: Hugo WB, ed. Inhibition and Destruction of the Microbial Cell. New York: Academic Press; 1971:209-224.
25. Hukari R, Helander IM, Vaara M. Chain length heterogeneity of lipopolysaccharide released from Salmonella typhimurium by ethylenediaminetetraacetic acid or polycations. Eur J Biochem 1986;154:673-676.
26. Said AA, Livermore DM, Williams RJ. Expression of H1 outer-membrane protein of Pseudomonas aeruginosa in relation to sensitivity to EDTA and polymyxin. J Med Microbiol 1987;24:267-274.
27. Nakaido H, Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 1985;49:1-32.
28. Gil ML, Casanova M, Martinez JP. Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA. Arch Microbiol 1994;161:489-494.
29. Sen BH, Akdeniz BG, Denizei AA. The effect of ethylenediamine-tetraacetic acid on Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:651-655.
30. Turakhia MH, Cooksey KE, Characklis WG. Influence of a calcium-specific chelant on biofilm removal. Appl Environ Microbiol 1983;46: 1236-1238.
31. Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control 2002;30:288-295.